Chrome 2001
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
. .

Carepass Ad Carepass Ad .
Chrome 2001
Chrome 2001

Hard to Find Good Info on Drug Safety in Pregnancy
WASHINGTON (AP) -- Nearly every woman takes a medication at some point during pregnancy. Yet there's disturbingly little easy-to-understand information about which drugs pose a risk to her baby, and what to do about it.
Another Study Strikes at the Heart of Niacin Benefits: There Are None
(USA TODAY) -- Niacin, a B vitamin that has been a mainstay of heart treatment for years, provided no benefit in a major new study and may even cause harm.
US Probes Sanofi over Blockbuster Drug Plavix
PARIS (AP) -- The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Child's HIV Cure is Met with Caution, Excitement
(USA TODAY) -- More than 300,000 babies a year worldwide are born infected with HIV, the virus that causes AIDS.
India Rejects Bayer Plea against Cheap Cancer Drug
NEW DELHI (AP) -- India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive lifesaving medicines to the poor.
UN Drug Body Calls for Crackdown on Legal Highs
VIENNA (Deutsche Presse-Agentur) -- Drug users around the globe are increasingly turning to medicines and to new substances that are not yet banned, the UN drug control board warned Tuesday, calling on governments to fight this trend.
Scientists Say Baby Born with HIV Apparently Cured
WASHINGTON (AP) -- A baby born with the virus that causes AIDS appears to have been cured, scientists announced Sunday, describing the case of a child from Mississippi who's now 2 1/2 and has been off medication for about a year with no signs of infection.
CEO: Risks Key for Merck to Succeed, Help Patients
NEW YORK (AP) -- Merck & Co. CEO Kenneth C. Frazier is convinced nearly everyone, from patients to long-term investors, wants the world's third-largest drugmaker to take big risks.
Researchers Say They May Have Found Cure for Acne
TORRANCE, Calif. (The New York Times News Service) -- Local researchers hope they have stumbled onto a safe and highly effective cure for acne, thanks to years of studying why some people get zits and others don't.
U.S. FDA Halts Pediatric Studies of Amgen Parathyroid Drug after 14-Year-Old Dies
WASHINGTON (Canadian Press) -- U.S. government health regulators have halted Amgen's studies of its drug Sensipar after the death of a 14-year-old patient in a company trial.


This website is certified by Health On the Net Foundation. Click to verify.